volume 41 issue 1 pages 53-77

Tumor Cell Death Induced by Topoisomerase-Targeting Drugs

Tsai-Kun Li 1
Leroy F. Liu 1
1
 
Department of Pharmacology, UMDNJ-Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway, New Jersey 08854;,,
Publication typeJournal Article
Publication date2001-04-11
scimago Q1
wos Q1
SJR4.029
CiteScore27.4
Impact factor13.1
ISSN03621642, 15454304
Pharmacology
Toxicology
Abstract

DNA topoisomerases are double-edged swords. They are essential for many vital functions of DNA during normal cell growth. However, they are also highly vulnerable under various physiological and nonphysiological stresses because of their delicate act on breaking and rejoining DNA. These stresses (e.g. exposure to topoisomerase poisons, acidic pH, and oxidative stresses) can convert DNA topoisomerases into DNA-breaking nucleases, resulting in cell death and/or genomic instability. The importance of topoisomerase-mediated DNA cleavage in tumor cell death and carcinogenesis has been recognized. This review focuses on recent findings concerning the molecular mechanisms of the stress responses to topoisomerase-mediated DNA damage. The involvement of ubiquitin/26S proteasome and SUMO/UBC9 in these processes, as well as the role of topoisomerase cleavable complexes in apoptotic cell death are discussed.

Found 
Found 

Top-30

Journals

5
10
15
20
25
30
35
40
Journal of Biological Chemistry
37 publications, 8.87%
Bioorganic and Medicinal Chemistry
15 publications, 3.6%
PLoS ONE
10 publications, 2.4%
Nucleic Acids Research
10 publications, 2.4%
Cancer Research
10 publications, 2.4%
Bioorganic and Medicinal Chemistry Letters
9 publications, 2.16%
Molecular Cancer Therapeutics
8 publications, 1.92%
Proceedings of the National Academy of Sciences of the United States of America
8 publications, 1.92%
Cancer Chemotherapy and Pharmacology
7 publications, 1.68%
Oncogene
7 publications, 1.68%
Journal of Inorganic Biochemistry
6 publications, 1.44%
European Journal of Medicinal Chemistry
6 publications, 1.44%
Molecular Pharmacology
5 publications, 1.2%
Biochemical Pharmacology
5 publications, 1.2%
Journal of Molecular Biology
5 publications, 1.2%
Molecular and Cellular Biology
5 publications, 1.2%
Cancer Drug Discovery and Development
5 publications, 1.2%
Biochemical and Biophysical Research Communications
4 publications, 0.96%
DNA Repair
4 publications, 0.96%
European Journal of Pharmacology
4 publications, 0.96%
Bioorganic Chemistry
4 publications, 0.96%
Dalton Transactions
4 publications, 0.96%
Anti-Cancer Drugs
3 publications, 0.72%
Scientific Reports
3 publications, 0.72%
Nature
3 publications, 0.72%
Inorganica Chimica Acta
3 publications, 0.72%
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
3 publications, 0.72%
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
3 publications, 0.72%
Chemical Research in Toxicology
3 publications, 0.72%
5
10
15
20
25
30
35
40

Publishers

20
40
60
80
100
120
Elsevier
115 publications, 27.58%
Springer Nature
68 publications, 16.31%
American Society for Biochemistry and Molecular Biology
37 publications, 8.87%
Wiley
30 publications, 7.19%
American Association for Cancer Research (AACR)
21 publications, 5.04%
American Chemical Society (ACS)
19 publications, 4.56%
Oxford University Press
16 publications, 3.84%
Taylor & Francis
10 publications, 2.4%
Public Library of Science (PLoS)
10 publications, 2.4%
Royal Society of Chemistry (RSC)
8 publications, 1.92%
Proceedings of the National Academy of Sciences (PNAS)
8 publications, 1.92%
American Society for Microbiology
7 publications, 1.68%
Cold Spring Harbor Laboratory
7 publications, 1.68%
MDPI
6 publications, 1.44%
Spandidos Publications
5 publications, 1.2%
Ovid Technologies (Wolters Kluwer Health)
5 publications, 1.2%
American Society for Pharmacology and Experimental Therapeutics
4 publications, 0.96%
Frontiers Media S.A.
4 publications, 0.96%
Mary Ann Liebert
3 publications, 0.72%
Bentham Science Publishers Ltd.
2 publications, 0.48%
Radiation Research Society
2 publications, 0.48%
European Molecular Biology Organization
2 publications, 0.48%
Hindawi Limited
2 publications, 0.48%
British Institute of Radiology
1 publication, 0.24%
The Company of Biologists
1 publication, 0.24%
Impact Journals
1 publication, 0.24%
Portland Press
1 publication, 0.24%
Pharmaceutical Society of Japan
1 publication, 0.24%
Pharmaceutical Society of Korea
1 publication, 0.24%
20
40
60
80
100
120
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
417
Share
Cite this
GOST |
Cite this
GOST Copy
Li T., Liu L. F. Tumor Cell Death Induced by Topoisomerase-Targeting Drugs // Annual Review of Pharmacology and Toxicology. 2001. Vol. 41. No. 1. pp. 53-77.
GOST all authors (up to 50) Copy
Li T., Liu L. F. Tumor Cell Death Induced by Topoisomerase-Targeting Drugs // Annual Review of Pharmacology and Toxicology. 2001. Vol. 41. No. 1. pp. 53-77.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1146/annurev.pharmtox.41.1.53
UR - https://doi.org/10.1146/annurev.pharmtox.41.1.53
TI - Tumor Cell Death Induced by Topoisomerase-Targeting Drugs
T2 - Annual Review of Pharmacology and Toxicology
AU - Li, Tsai-Kun
AU - Liu, Leroy F.
PY - 2001
DA - 2001/04/11
PB - Annual Reviews
SP - 53-77
IS - 1
VL - 41
PMID - 11264450
SN - 0362-1642
SN - 1545-4304
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2001_Li,
author = {Tsai-Kun Li and Leroy F. Liu},
title = {Tumor Cell Death Induced by Topoisomerase-Targeting Drugs},
journal = {Annual Review of Pharmacology and Toxicology},
year = {2001},
volume = {41},
publisher = {Annual Reviews},
month = {apr},
url = {https://doi.org/10.1146/annurev.pharmtox.41.1.53},
number = {1},
pages = {53--77},
doi = {10.1146/annurev.pharmtox.41.1.53}
}
MLA
Cite this
MLA Copy
Li, Tsai-Kun, and Leroy F. Liu. “Tumor Cell Death Induced by Topoisomerase-Targeting Drugs.” Annual Review of Pharmacology and Toxicology, vol. 41, no. 1, Apr. 2001, pp. 53-77. https://doi.org/10.1146/annurev.pharmtox.41.1.53.